Métabolisme et fonctions des acides gras oméga-3 à longue chaîne ...

Références Bibliographiques
Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez
JM, Chiang N, Serhan CN and Bazan NG. Novel docosanoids inhibit brain ischemiareperfusion-mediated
leukocyte infiltration and pro-inflammatory gene expression. J. Biol.
Chem. 2003, 278: 43807-43817.
Mason MM, He Y, Chen H, Quon MJ and Reitman M. Regulation of leptin promoter
function by Sp1, C/EBP, and a novel factor. Endocrinology. 1998, 139: 1013-1022.
Massiera F, Saint-Marc P, Seydoux J, Murata T, Kobayashi T, Narumiya S, Guesnet P,
Amri EZ, Negrel R and Ailhaud G. Arachidonic acid and prostacyclin signaling promote
adipose tissue development: a human health concern? J. Lipid Res. 2003, 44: 271-279.
Matsubara M, Maruoka S and Katayose S. Decreased plasma adiponectine concentrations
in women with dyslipidemia. J. Clin. Endocrinol. Metab. 2002, 87: 2764-2769.
Mead JR, Irvine SA and Ramji D. Lipoprotein lipase: structure, fonction, regulation and
role in disease. J. Mol. Med. 2002, 80: 753-769.
Mebarek S, Ermak N, Benzaria A, Vicca S, Dubois M, Némoz G, Laville M, Lacour B,
Véricel E, Lagarde M and Prigent AF. Effects of increasing docosahexaenoic acid intake in
human healthy volunteers on lymphocyte activation and monocyte apoptosis. Br. J. Nutr.
2009, 101: 852-858.
Mendez M & LaPointe MC. PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase,
and inducible nitric oxide synthase in cardiac myocytes. Hypertension. 2003, 42: 844-850.
Miller SG, De Vos P, Guerre-Millo M, Wong K, Hermann T, Staels B, Briggs MR and
Auwerx J. The adipocyte specific transcription factor C/EBPalpha modulates human ob gene
expression. Proc. Natl. Acad. Sci. U S A. 1996, 93: 5507-5511.
Misra A & Vikram NK. Clinical and pathophysiological consequences of abdominal
adiposity and abdominal adipose tissue depots. Nutrition. 2003, 19: 457-466.
Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S and
Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis
factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 1997, 82: 4196-4200.
Mohamed-Ali V, Flower L, Sethi J, Hotamisligil G, Gray R, Humphries SE, York DA
and Pinkney J. Beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in
vitro studies. J. Clin. Endocrinol. Metab. 2001, 86: 5864-5869.
147